Tumour-infiltrating bystander CD8+ T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer.
Galam LeemMinwoo JeonKun Woo KimSeongju JeongSeong Jin ChoiYong Joon LeeEui-Soon KimJae-Ik LeeSeung Yeon HaSu-Hyung ParkHyo Sup ShimJin Gu LeeShin Myung KangEui-Cheol ShinPublished in: Thorax (2021)
Thus, the study demonstrates that bystander CD8+ TILs can be repurposed by IL-15 for tumour immunotherapy.
Keyphrases